Evidence map›Paper›PMID 39065736›Full record

ArticlePharmaceuticals (Basel, Switzerland)2024

Unraveling the Potential of

Hanem F El-Gendy, Amanallah El-Bahrawy, Doaa A Mansour, Nagwa I Sheraiba, Nazema S Abdel-Megeid, Shaimaa Selim, Rashed A Alhotan, Anam Ayyoub, Saber El Hanbally

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Protective Impacts ofLife (Basel, Switzerland) · 2025
    Article
  2. Article
  3. Article
  4. Unveiling the Potential of Silymarin,Life (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hanem F El-GendyDepartment of Pharmacology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Amanallah El-BahrawyDepartment of Pathology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Doaa A MansourDepartment of Biochemistry and Chemistry of Nutrition, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Nagwa I SheraibaDepartment of Husbandry and Animal Wealth Development, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.ORCID 0000-0002-4239-543X
Nazema S Abdel-MegeidDepartment of Cytology and Histology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.
Shaimaa SelimDepartment of Nutrition and Clinical Nutrition, Faculty of Veterinary Medicine, Menoufia University, Shibin El-Kom 32514, Egypt.ORCID 0000-0001-7013-8273
Rashed A AlhotanDepartment of Animal Production, College of Food and Agriculture Sciences, King Saud University, Riyadh 11451, Saudi Arabia.ORCID 0000-0002-7789-4722
Anam AyyoubCollege of Life Sciences, Northwest A & F University, Yangling District, Xianyang 712100, China.
Saber El HanballyDepartment of Pharmacology, Faculty of Veterinary Medicine, University of Sadat City, Sadat City 32897, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

5-Fluorouracil (5-FU) is often used as a chemotherapeutic agent in treating tumors and is said to have adverse effects, including nephrotoxicity. Therefore, the present study aimed to evaluate the protective effects of

Indexed as

5-fluorouracilantioxidantChlorella vulgarisinflammatory cytokinenephrotoxicityratsSaccharum officinarum

Identifiers

PMID39065736
PMCPMC11279568

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.